NZ331600A - Novel erythromycin derivatives, method for preparing same, and use thereof as drugs that have antibiotic properties - Google Patents
Novel erythromycin derivatives, method for preparing same, and use thereof as drugs that have antibiotic propertiesInfo
- Publication number
- NZ331600A NZ331600A NZ331600A NZ33160097A NZ331600A NZ 331600 A NZ331600 A NZ 331600A NZ 331600 A NZ331600 A NZ 331600A NZ 33160097 A NZ33160097 A NZ 33160097A NZ 331600 A NZ331600 A NZ 331600A
- Authority
- NZ
- New Zealand
- Prior art keywords
- drugs
- preparing same
- antibiotic properties
- erythromycin derivatives
- novel erythromycin
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9602472A FR2745290B1 (fr) | 1996-02-28 | 1996-02-28 | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| PCT/FR1997/000351 WO1997031929A1 (fr) | 1996-02-28 | 1997-02-27 | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ331600A true NZ331600A (en) | 1999-08-30 |
Family
ID=9489659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ331600A NZ331600A (en) | 1996-02-28 | 1997-02-27 | Novel erythromycin derivatives, method for preparing same, and use thereof as drugs that have antibiotic properties |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6096714A (enExample) |
| EP (1) | EP0885234B1 (enExample) |
| JP (1) | JP4102440B2 (enExample) |
| KR (1) | KR100486053B1 (enExample) |
| CN (1) | CN1168734C (enExample) |
| AP (1) | AP952A (enExample) |
| AR (1) | AR005999A1 (enExample) |
| AT (1) | ATE217633T1 (enExample) |
| AU (1) | AU716204B2 (enExample) |
| BG (1) | BG63207B1 (enExample) |
| BR (1) | BR9707709B1 (enExample) |
| CZ (1) | CZ293893B6 (enExample) |
| DE (1) | DE69712610T2 (enExample) |
| DK (1) | DK0885234T3 (enExample) |
| EA (1) | EA001376B1 (enExample) |
| EE (1) | EE9800265A (enExample) |
| ES (1) | ES2176698T3 (enExample) |
| FR (1) | FR2745290B1 (enExample) |
| HU (1) | HU227567B1 (enExample) |
| IL (1) | IL125622A (enExample) |
| NO (1) | NO983955L (enExample) |
| NZ (1) | NZ331600A (enExample) |
| OA (1) | OA10845A (enExample) |
| PL (1) | PL191736B1 (enExample) |
| PT (1) | PT885234E (enExample) |
| SK (1) | SK118498A3 (enExample) |
| TR (1) | TR199801713T2 (enExample) |
| UA (1) | UA58504C2 (enExample) |
| WO (1) | WO1997031929A1 (enExample) |
| YU (1) | YU37098A (enExample) |
| ZA (1) | ZA971659B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004514643A (ja) * | 1997-10-29 | 2004-05-20 | 大正製薬株式会社 | エリスロマイシンａ誘導体 |
| WO1999021869A1 (en) * | 1997-10-29 | 1999-05-06 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a, 11,12-carbamate derivatives |
| FR2780977B1 (fr) * | 1998-07-09 | 2000-09-01 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| JP4573925B2 (ja) * | 1998-07-09 | 2010-11-04 | アベンティス・ファーマ・ソシエテ・アノニム | 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用 |
| FR2792637B1 (fr) * | 1999-04-26 | 2001-06-01 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| FR2781484B1 (fr) * | 1998-07-21 | 2001-08-10 | Hoechst Marion Roussel Inc | Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments |
| DK1147121T3 (da) | 1999-01-27 | 2004-04-13 | Pfizer Prod Inc | Ketolidantibiotika |
| EE200100613A (et) * | 1999-05-24 | 2003-02-17 | Pfizer Products Inc. | 13-metüülerütromütsiini derivaadid |
| AU6183800A (en) * | 1999-08-06 | 2001-03-05 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
| WO2001010878A1 (fr) * | 1999-08-06 | 2001-02-15 | Taisho Pharmaceutical Co., Ltd. | Derives d'erythromycine a |
| AU6316400A (en) * | 1999-08-06 | 2001-03-05 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
| EP1146051A3 (en) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Erythromycin A derivatives |
| US20020115621A1 (en) * | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
| ITMI20021726A1 (it) * | 2002-08-01 | 2004-02-02 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria. |
| US7601695B2 (en) | 2003-03-10 | 2009-10-13 | Optimer Pharmaceuticals, Inc. | Antibacterial agents |
| WO2005007143A2 (en) * | 2003-07-14 | 2005-01-27 | The Board Of Trustees Of The University Of Illinois | Use of makrolides and ketolides for the treatment of tuberculosis |
| WO2007069264A2 (en) * | 2005-12-15 | 2007-06-21 | Alembic Limited | Reference standards for determining the purity of telithromycin and processes therefor |
| AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| CN107854477A (zh) | 2008-10-24 | 2018-03-30 | 森普拉制药公司 | 使用含三唑的大环内酯治疗抗性疾病的方法 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| US9480679B2 (en) | 2009-09-10 | 2016-11-01 | Cempra Pharmaceuticals, Inc. | Methods for treating malaria, tuberculosis and MAC diseases |
| HRP20160168T1 (hr) | 2010-03-22 | 2016-03-25 | Cempra Pharmaceuticals Inc | Kristalne forme makrolida i njihova uporaba |
| BR112012029586A2 (pt) | 2010-05-20 | 2016-08-02 | Cempra Pharmaceuticals Inc | processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos |
| KR20130120458A (ko) | 2010-09-10 | 2013-11-04 | 셈프라 파마슈티컬스, 인크. | 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드 |
| WO2013148891A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
| WO2014152326A1 (en) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| AU2014233240B2 (en) | 2013-03-15 | 2018-08-09 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US487411A (en) * | 1892-12-06 | Island | ||
| IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
| US5444031A (en) * | 1993-01-21 | 1995-08-22 | Calgon Carbon Corporation | Process for making catalytic carbon |
| FR2727969B1 (fr) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
-
1996
- 1996-02-28 FR FR9602472A patent/FR2745290B1/fr not_active Expired - Lifetime
-
1997
- 1997-02-25 AR ARP970100760A patent/AR005999A1/es unknown
- 1997-02-26 ZA ZA9701659A patent/ZA971659B/xx unknown
- 1997-02-27 WO PCT/FR1997/000351 patent/WO1997031929A1/fr not_active Ceased
- 1997-02-27 BR BRPI9707709-7A patent/BR9707709B1/pt not_active IP Right Cessation
- 1997-02-27 IL IL12562297A patent/IL125622A/xx not_active IP Right Cessation
- 1997-02-27 CZ CZ19982587A patent/CZ293893B6/cs not_active IP Right Cessation
- 1997-02-27 DK DK97907141T patent/DK0885234T3/da active
- 1997-02-27 PT PT97907141T patent/PT885234E/pt unknown
- 1997-02-27 US US09/125,959 patent/US6096714A/en not_active Ceased
- 1997-02-27 DE DE69712610T patent/DE69712610T2/de not_active Expired - Lifetime
- 1997-02-27 EP EP97907141A patent/EP0885234B1/fr not_active Expired - Lifetime
- 1997-02-27 CN CNB971926255A patent/CN1168734C/zh not_active Expired - Lifetime
- 1997-02-27 JP JP53067197A patent/JP4102440B2/ja not_active Expired - Lifetime
- 1997-02-27 ES ES97907141T patent/ES2176698T3/es not_active Expired - Lifetime
- 1997-02-27 KR KR10-1998-0706733A patent/KR100486053B1/ko not_active Expired - Lifetime
- 1997-02-27 NZ NZ331600A patent/NZ331600A/xx unknown
- 1997-02-27 AT AT97907141T patent/ATE217633T1/de active
- 1997-02-27 TR TR1998/01713T patent/TR199801713T2/xx unknown
- 1997-02-27 UA UA98095031A patent/UA58504C2/uk unknown
- 1997-02-27 HU HU9902576A patent/HU227567B1/hu unknown
- 1997-02-27 EA EA199800768A patent/EA001376B1/ru not_active IP Right Cessation
- 1997-02-27 AU AU19298/97A patent/AU716204B2/en not_active Expired
- 1997-02-27 EE EE9800265A patent/EE9800265A/xx unknown
- 1997-02-27 AP APAP/P/1998/001318A patent/AP952A/en active
- 1997-02-27 PL PL328608A patent/PL191736B1/pl unknown
- 1997-02-27 SK SK1184-98A patent/SK118498A3/sk unknown
-
1998
- 1998-08-12 BG BG102691A patent/BG63207B1/bg unknown
- 1998-08-27 NO NO983955A patent/NO983955L/no not_active Application Discontinuation
- 1998-08-28 YU YU37098A patent/YU37098A/sh unknown
- 1998-08-28 OA OA9800150A patent/OA10845A/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9503505D0 (en) | Novel erythromycin derivatives, method for preparing same and use thereof as drugs | |
| HU9603038D0 (en) | Novel erythromycin derivatives, method for their preparation and their use as drugs | |
| HUP9902576A3 (en) | Novel erythromycin derivatives, method for preparing them, and use thereof as drugs | |
| HUP0002252A3 (en) | 9-oxime erythromycin derivatives, process for preparing them and pharmaceutical compositions containing them | |
| HUT70411A (en) | Antiparasitic avermectin derivatives, process for preparing them and pharmaceutical compositions containing them | |
| HUP0001115A3 (en) | Heterocyclylmethyl-substituted pyrazol derivatives, process for their preparation and pharmaceuticals containing the same | |
| HUP9900056A2 (hu) | Szubsztituált 4-fenil-amino-tiazol-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
| HUP0003267A3 (en) | Heteroaryl derivatives, pharmaceutical compositions containing them and process for producing them | |
| HRP20010335B1 (en) | Novel erythromycin derivatives, preparation method and use as medicines | |
| HUP9903424A3 (en) | Novel erythromycin derivatives,method for preparing same and use thereof as drugs | |
| IL130420A (en) | Erythromycin derivatives, method for preparing them and their use as medicine | |
| AU7847298A (en) | Novel substituted 3H -benzoxazole-2-thiones and 3H -benzothiazole-2thi ones derivatives, method for preparing them and pharmaceutical comp ositions containing them | |
| PL334134A1 (en) | Novel derivatives of erythromycin, method of obtaining them and their application as drugs | |
| HU9502434D0 (en) | Antibiotic wap-8294a, method for preparing the same and antibacterial composition | |
| HUP0103997A3 (en) | Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines | |
| AU4722996A (en) | Epipodophyllotoxin triaryloxyacetyl derivatives, method for preparing same, and use of said derivatives as cancer drugs | |
| AU5008096A (en) | Pharmaceutical compositions containing l-etrabamine, uses thereof, and methods for preparing same | |
| AU6886896A (en) | Phenylbutanol derivatives, methods for their preparation and pharmaceutical compositions thereof | |
| HU9701216D0 (en) | New nitropyrazolester derivatives, process for their preparation and their use | |
| ZA956827B (en) | Antibiotic WAP-8294A method for preparing the same and antibacterial composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: AVENTIS PHARMA S.A., FR Free format text: OLD OWNER(S): HOECHST MARION ROUSSEL |